Pharmaceutical/biotech - Articles - Page 13

Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

September 20, 2018

The Wall Street Journal

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

When Your Prescription Drug Is Tainted With a Chemical 'Used to Make Rocket Fuel'

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

September 12, 2018

Los Angeles Times

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

Hospitals Are Fed Up With Drug Companies, So They're Starting Their Own

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

September 7, 2018

Los Angeles Times

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

Pfizer's Costly Divorce: Pharma Giant Says Brexit Will Cost It $100M

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.

September 5, 2018

Fortune

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.

Supply Chain Delivers Healthcare Value in the Real World

As any supply chain professional knows, sourcing is a critical element of effective procurement.

August 27, 2018

Karen Conway, SCB Contributor

As any supply chain professional knows, sourcing is a critical element of effective procurement.

Five Emerging Tech Trends That Blur the Lines Between Human and Machine

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

August 21, 2018

Gartner

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

Big Tech's New Alliance Is Good News for the Health of A.I.

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

August 14, 2018

Fortune

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

Regeneron’s Billionaire Founder Battles the Drug Pricing System

Sipping a lemon-flavored VitaminWater at a sprawling complex of laboratories and offices in Tarrytown, New York, Leonard Schleifer, the 66-year-old cofounder of Regeneron Pharmaceuticals, is, as usual, criticizing the pricing practices of other drug companies. (He once told the chief executive of Pfizer: "You're not entitled to a fraction of the GDP.")

July 30, 2018

Forbes

Sipping a lemon-flavored VitaminWater at a sprawling complex of laboratories and offices in Tarrytown, New York, Leonard Schleifer, the 66-year-old cofounder of Regeneron Pharmaceuticals, is, as usual, criticizing the pricing practices of other drug companies. (He once told the chief executive of Pfizer: "You're not entitled to a fraction of the GDP.")

Podcast | Can Big Data Get Too Big?

Are businesses surfing the wave of big data? Or are they drowning in it?

July 27, 2018

Robert J. Bowman, SupplyChainBrain

Yes, Supply Chain Can Power Population Health

"It was the best of times, it was the worst of times.” The opening line of Charles Dickens’ A Tale of Two Cities contrasts the cities of Paris and London during the French Revolution. In many ways, however, those words describe the state of the U.S. healthcare system today.

July 12, 2018

Karen Conway, SCB Contributor

"It was the best of times, it was the worst of times.” The opening line of Charles Dickens’ A Tale of Two Cities contrasts the cities of Paris and London during the French Revolution. In many ways, however, those words describe the state of the U.S. healthcare system today.